Answers are grounded in this paper and cite their sources.
Since the 2000s, we have known that female genital schistosomiasis (FGS) is likely the most neglected gynecologic condition and HIV/AIDS cofactor across sub-Saharan Africa. To date, the global health and HIV/AIDS communities have not used the opportunity to prevent new HIV/AIDS infections through highly cost-effective schistosomiasis control and elimination in Africa. But recently, this situation may be shifting toward the better.
No takes yet. Share an insight, caveat, or question.
Hotez et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: